封面
市場調查報告書
商品編碼
1279647

2022-2029年全球精準醫療市場規模研究和預測,按技術和應用及區域分析

Global Precision Medicine Market Size study & Forecast, by Technology by Application, and Regional Analysis, 2022-2029

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

精準醫學是一門新興的科學,它將治療決定集中在病人的基因特徵、生活方式和環境上。精準醫學在治療癌症方面的成功促使了它的普及。它使醫學專家和研究人員能夠預測每一種具體疾病的更精確的治療和預防措施。精準醫學的關注重點在於健康身體細胞變成癌細胞的突變,通常被稱為個性化醫學或定制醫學。與傳統藥物相比,精準醫學在癌症靶向治療中的應用提供了更少的不良反應,促進了更快的康復。由於中樞神經系統疾病發病率的增加和癌症生物學的進步等因素,精準醫學市場正在擴大。

由於包括癌症和不常見疾病在內的嚴重疾病的患病率上升,該領域已經創建了幾種基因療法,診斷和藥物。根據國際癌症研究機構(IARC)的估計,在全球範圍內,2018年有1700萬個新的癌症病例和950萬個癌症相關的死亡病例。據估計,到2040年,全世界的癌症負擔將增加到2750萬新病例。此外,細胞生物學和技術的發展正在推動審查中的行業的發展。例如,2021年5月,AdventHealth推出了一個數據驅動的精準醫療計劃,作為其基因組學計劃擴展的一部分。這項計劃組織和整合縱向病人數據與分子測試數據,從而建立一個數據集和疾病網路模型,幫助醫療系統更好地預測疾病的發生以及它們對治療的反應。因此,這些發展正在推動增長。此外,精準醫療的技術進步和與精準醫療相關的投資增長正在為市場創造一個有利可圖的增長。然而,精準醫療發展的高成本阻礙了市場增長。

全球精準醫療市場研究的主要地區包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於品牌技術的主導地位和該地區日益增長的疾病流行率,北美在收入方面主導了市場。而亞太地區在預測期內預計將以最高的複合年增長率增長,原因是老年病的增加、藥品開發合作數量的增加、主要參與者的地理擴張以及政府和非營利組織在市場空間的積極參與等因素。

該研究的目的是定義近年來不同市場區隔和國家的市場規模,並預測未來幾年的價值。該報告旨在涵蓋參與研究的國家/地區的該行業的定性和定量方面。

該報告還提供了關於關鍵方面的詳細資訊,如驅動因素和挑戰,這將確定市場的未來增長。此外,它還涵蓋了微觀市場的潛在機會,供利益相關者投資,以及對競爭格局和主要參與者的技術產品的詳細分析。 .

目錄

第一章:執行摘要

  • 市場簡介
  • 2019-2029年全球和細分市場的估計和預測
    • 2019-2029年精準醫療市場,按地區分類
    • 2019-2029年精準醫療市場,按技術分類
    • 2019-2029年精準醫療市場,按應用分類
  • 主要趨勢
  • 估算方法
  • 研究假設

第二章:全球精準醫療市場的定義和範圍

  • 本研究的目的
  • 市場定義和範圍
    • 研究的範圍
    • 行業演變
  • 研究涵蓋的年份
  • 貨幣兌換率

第三章:全球精準醫療市場動態

  • 精準醫療市場影響分析(2019-2029年)
    • 市場驅動力
      • 中樞神經系統疾病的發病率不斷上升
      • 癌症生物學的進步
    • 市場挑戰
      • 精準醫療發展的高成本
    • 市場機會
      • 精準醫療的技術進步
      • 與精準醫療相關的投資不斷增長

第四章:全球精準醫療市場行業分析

  • 波特的5力模型
    • 供應商的議價能力
    • 買方的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭性的競爭
  • 波特五力模型的未來方法(2019-2029年)
  • PEST分析
    • 政治因素
    • 經濟
    • 社會
    • 技術
  • 最佳投資機會
  • 最佳策略
  • 行業專家展望
  • 分析師建議和結論

第五章:風險評估:COVID-19的影響

  • 評估COVID-19對行業的整體影響
  • COVID-19前和COVID-19後的市場情況

第六章:全球精準醫療市場,按技術分類

  • 市場簡介
  • 按技術分類的全球精準醫療市場,性能-潛力分析
  • 2019-2029年全球精準醫療市場按技術的估計和預測
  • 精準醫療市場,細分領域分析
    • 大數據分析
    • 生物資訊學
    • 基因測序
    • 藥物發現
    • 伴隨診斷
    • 其他技術

第7章:全球精準醫療市場,按應用分類

  • 市場簡介
  • 全球精準醫療市場,按應用,性能- 潛力分析
  • 2019-2029年全球精準醫療市場按應用估計和預測的情況
  • 精準醫療市場,細分領域分析
    • 腫瘤學
    • 中樞神經系統
    • 免疫學
    • 呼吸系統
    • 其他應用

第八章:全球精準醫療市場,區域分析

  • 精準醫療市場,區域市場簡介
  • 北美洲
    • 美國
      • 技術細分估計和預測,2019-2029年
      • 2019-2029年應用細分估計和預測
    • 加拿大
  • 歐洲精準醫療市場簡介
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區精準醫療市場簡述
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 拉美地區精準醫療市場簡介
    • 巴西
    • 墨西哥
    • 拉美其他地區
  • 世界其他地區

第九章:競爭情報

  • 頂級市場戰略
  • 公司簡介
    • Astarte Medical
      • 關鍵資訊
      • 概況
      • 財務(取決於數據的可用性)
      • 產品摘要
      • 近期發展情況
    • AstraZeneca PLC
    • F Hoffmann-La Roche Ltd.
    • Laboratory Corporation of America Holdings
    • Medtronic PLC
    • Myriad Genetics Inc.
    • Novartis AG
    • Pfizer Inc.
    • Qiagen NV
    • Quest Diagnostics

第十章:研究過程

  • 研究過程
    • 資料探勘
    • 數據分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global Precision Medicine Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Precision medicine is an emerging science that focuses treatment decisions on a patient's genetic profile, way of life, and environment. The success of precision medicine in treating cancer has led to an increase in its popularity. It enables medical professionals and researchers to forecast more precise treatment and prevention measures for every specific disease. Precision medicine, which focuses on the mutations that turn healthy bodily cells into cancerous ones, is often referred to as personalized medicine or tailored medicine. In comparison to conventional medications, the use of precision medicine in targeted cancer treatment offers fewer adverse effects and promotes faster recovery. The Precision Medicine market is expanding because of factors such as increasing incidence of central nerves system disorders and advancement in cancer biology.

Several gene therapies, diagnostics, and medications have been created in this field as a result of the rise in the prevalence of serious illnesses including cancer and uncommon diseases. According to estimates from the International Agency for Research on Cancer (IARC), globally, there were 17.0 million new instances of cancer and 9.5 million cancer-related deaths in 2018. It is estimated to increase the worldwide burden of cancer to 27.5 million new cases by 2040. Furthermore, the development of the industry under review is being fueled by developments in cell biology and technology. For instance, in May 2021, AdventHealth launched a data-driven precision medicine initiative as part of the expansion of its genomics programme. This initiative organize and integrate longitudinal patient data with molecular testing data, resulting in the creation of a dataset and disease network models that will aid the healthcare system in better anticipating the onset of diseases and how they will respond to treatments. Thus, these developments are fueling the growth. In addition, higher technological advancements of precision medicine and growing investments associated with precision medicine is creating a lucrative growth to the market. However, high cost for precision medicine development halt market growth.

The key regions considered for the Global Precision Medicine Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded Technologies and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric, an increase in the number of collaborations for medicine development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Astarte Medical
  • AstraZeneca PLC
  • F Hoffmann-La Roche Ltd.
  • Laboratory Corporation of America Holdings
  • Medtronic PLC
  • Myriad Genetics Inc.
  • Novartis AG
  • Pfizer Inc.
  • Qiagen NV
  • Quest Diagnostics

Recent Developments in the Market:

  • In November 2022, The University of Pecs (UP) and BGI Genomics decided to open a collaborative lab in Hungary. The collaborative lab will begin formal operations in order to strengthen BGI Genomics' and the UP's avant-garde precision medicine advancements in the Central and Eastern European region and to speed the development of genomic sequencing and clinical diagnostic services.

Global Precision Medicine Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Technology, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Technology:

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Other Technologies

By Application:

  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Other Applications

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Precision Medicine Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Precision Medicine Market, by Technology, 2019-2029 (USD Billion)
    • 1.2.3. Precision Medicine Market, by Application, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Precision Medicine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Precision Medicine Market Dynamics

  • 3.1. Precision Medicine Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of Central Nerves System disorders
      • 3.1.1.2. Advancement in Cancer Biology
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost for precision medicine development
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Higher Technological Advancements of Precision Medicine
      • 3.1.3.2. Growing Investments Associated with Precision Medicine

Chapter 4. Global Precision Medicine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Precision Medicine Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global Precision Medicine Market by Technology, Performance - Potential Analysis
  • 6.3. Global Precision Medicine Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
  • 6.4. Precision Medicine Market, Sub Segment Analysis
    • 6.4.1. Big Data Analytics
    • 6.4.2. Bioinformatics
    • 6.4.3. Gene Sequencing
    • 6.4.4. Drug Discovery
    • 6.4.5. Companion Diagnostics
    • 6.4.6. Other Technologies

Chapter 7. Global Precision Medicine Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Precision Medicine Market by Application, Performance - Potential Analysis
  • 7.3. Global Precision Medicine Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 7.4. Precision Medicine Market, Sub Segment Analysis
    • 7.4.1. Oncology
    • 7.4.2. CNS
    • 7.4.3. Immunology
    • 7.4.4. Respiratory
    • 7.4.5. Other Applications

Chapter 8. Global Precision Medicine Market, Regional Analysis

  • 8.1. Precision Medicine Market, Regional Market Snapshot
  • 8.2. North America Precision Medicine Market
    • 8.2.1. U.S. Precision Medicine Market
      • 8.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Precision Medicine Market
  • 8.3. Europe Precision Medicine Market Snapshot
    • 8.3.1. U.K. Precision Medicine Market
    • 8.3.2. Germany Precision Medicine Market
    • 8.3.3. France Precision Medicine Market
    • 8.3.4. Spain Precision Medicine Market
    • 8.3.5. Italy Precision Medicine Market
    • 8.3.6. Rest of Europe Precision Medicine Market
  • 8.4. Asia-Pacific Precision Medicine Market Snapshot
    • 8.4.1. China Precision Medicine Market
    • 8.4.2. India Precision Medicine Market
    • 8.4.3. Japan Precision Medicine Market
    • 8.4.4. Australia Precision Medicine Market
    • 8.4.5. South Korea Precision Medicine Market
    • 8.4.6. Rest of Asia Pacific Precision Medicine Market
  • 8.5. Latin America Precision Medicine Market Snapshot
    • 8.5.1. Brazil Precision Medicine Market
    • 8.5.2. Mexico Precision Medicine Market
    • 8.5.3. Rest of Latin America Precision Medicine Market
  • 8.6. Rest of The World Precision Medicine Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Astarte Medical
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. AstraZeneca PLC
    • 9.2.3. F Hoffmann-La Roche Ltd.
    • 9.2.4. Laboratory Corporation of America Holdings
    • 9.2.5. Medtronic PLC
    • 9.2.6. Myriad Genetics Inc.
    • 9.2.7. Novartis AG
    • 9.2.8. Pfizer Inc.
    • 9.2.9. Qiagen NV
    • 9.2.10. Quest Diagnostics

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Precision Medicine Market, report scope
  • TABLE 2. Global Precision Medicine Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Precision Medicine Market estimates & forecasts by Technology 2019-2029 (USD Billion)
  • TABLE 4. Global Precision Medicine Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 5. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Precision Medicine Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Precision Medicine Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Precision Medicine Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Precision Medicine Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Precision Medicine Market
  • TABLE 70. List of primary sources, used in the study of global Precision Medicine Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Precision Medicine Market, research methodology
  • FIG 2. Global Precision Medicine Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Precision Medicine Market, key trends 2021
  • FIG 5. Global Precision Medicine Market, growth prospects 2022-2029
  • FIG 6. Global Precision Medicine Market, porters 5 force model
  • FIG 7. Global Precision Medicine Market, pest analysis
  • FIG 8. Global Precision Medicine Market, value chain analysis
  • FIG 9. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Precision Medicine Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Precision Medicine Market, regional snapshot 2019 & 2029
  • FIG 15. North America Precision Medicine Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Precision Medicine Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Precision Medicine Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Precision Medicine Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Precision Medicine Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable